Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Clin Pharmacol Ther. 2020 Jul 22;109(2):352–366. doi: 10.1002/cpt.1973

Table 2.

Novel allele(s) and confirmed suballele(s)

Core Allele
Designation		 Novel alleles/suballeles
*1 *1.004, *1.005
*2 *2.0010
*36 Complete deletion of CYP2C19 gene
*37 Partial deletion of CYP2C19 gene (i.e. deletions that include at least the entire exon 1)
Submissions for known alleles; original haplotype was confirmed, and evidence level raised to ‘Def’
*1.002, *2.002, *15.001, *17.001, and *35.001